Adenosine A2A receptor agonists inhibit lipopolysaccharide-induced production of tumor necrosis factor-α by equine monocytes

Veterinary Immunology and Immunopathology

Volumn 121, Issue 1-2, 2008, Pages 91-100

  Sun, Wan Chun ^a   Moore, James N ^a   Hurley, David J ^a   Vandenplas, Michel L ^a   Linden, Joel ^b   Cao, Zhengyu ^c   Murray, Thomas F ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adenosine receptor; Cyclic AMP; Lipopolysaccharide; Radioligand binding; Tumor necrosis factor

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 6 N (3 IODOBENZYL)ADENOSINE 5' N METHYLCARBOXAMIDE; 9 CHLORO 2 (2 FURYL) 5 PHENYLACETYLAMINO 1,2,4 TRIAZOLO[1,5 C]QUINAZOLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENYLATE CYCLASE; ATL 202; ATL 307; ATL 309; ATL 310; ATL 313; ATL 361; ATL 372; ATL 376; BUCLADESINE; CYCLIC AMP; FORSKOLIN; LIPOPOLYSACCHARIDE; MRS 1706; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADENOSINE; DRUG DERIVATIVE; PHENETHYLAMINE DERIVATIVE; PIPERIDINE DERIVATIVE; TRIAZINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG RECEPTOR BINDING; HORSE; IC 50; INFLAMMATION; MONOCYTE; NEUTROPHIL; NONHUMAN; RADIOASSAY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ANIMAL; BINDING COMPETITION; BIOSYNTHESIS; BLOOD; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME IMMUNOASSAY; IMMUNOLOGY; METABOLISM; REGRESSION ANALYSIS;

EQUIDAE;

ADENOSINE; ADENOSINE-5'-(N-ETHYLCARBOXAMIDE); ANIMALS; BINDING, COMPETITIVE; CYCLIC AMP; HORSES; IMMUNOENZYME TECHNIQUES; LIPOPOLYSACCHARIDES; MONOCYTES; PHENETHYLAMINES; PIPERIDINES; RECEPTOR, ADENOSINE A2A; REGRESSION ANALYSIS; TRIAZINES; TRIAZOLES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 36849015902     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2007.08.011     Document Type: Article

References (31)

1. Barton M.H., Collatos C., and Moore J.N. Endotoxin induced expression of tumour necrosis factor, tissue factor and plasminogen activator inhibitor activity by peritoneal macrophages. Equine Vet. J. 28 (1996) 382-389
2. Barton M.H., Morris D.D., Norton N., and Prasse K.W. Hemostatic and fibrinolytic indices in neonatal foals with presumed septicemia. J. Vet. Intern. Med. 12 (1998) 26-35
3. Bouma M.G., van den Wildenberg F.A., and Buurman W.A. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am. J. Physiol. 270 (1996) C522-C529
4. Brandon C.I., Vandenplas M., Dookwah H., Linden J., and Murray T.F. Cloning and pharmacological characterization of the equine adenosine A2A receptor: a potential therapeutic target for the treatment of equine endotoxemia. J. Vet. Pharmacol. Ther. 29 (2006) 243-253
5. Brandon C.I., Vandenplas M., Dookwah H., and Murray T.F. Cloning and pharmacological characterization of the equine adenosine A3 receptor. J. Vet. Pharmacol. Ther. 29 (2006) 255-263
6. Bshesh K., Zhao B., Spight D., Biaggioni I., Feokistov I., Denenberg A., Wong H.R., and Shanley T.P. The A2A receptor mediates an endogenous regulatory pathway of cytokine expression in THP-1 cells. J. Leukoc. Biol. 72 (2002) 1027-1036
7. Ezeamuzie C.I., and Khan I. The role of adenosine A(2) receptors in the regulation of TNF-alpha production and PGE(2) release in mouse peritoneal macrophages. Int. Immunopharmacol. 7 (2007) 483-490
8. Fredholm B.B., Ap I.J., Jacobson K.A., Klotz K.N., and Linden J. International union of pharmacology XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53 (2001) 527-552
9. Gomez G., and Sitkovsky M.V. Targeting G protein-coupled A2a adenosine receptors to engineer inflammation in vivo. Int. J. Biochem. Cell Biol. 35 (2003) 410-414
10. Hasko G., and Cronstein B.N. Adenosine: an endogenous regulator of innate immunity. Trends Immunol. 25 (2004) 33-39
11. Hasko G., Kuhel D.G., Chen J.F., Schwarzschild M.A., Deitch E.A., Mabley J.G., Marton A., and Szabo C. Adenosine inhibits IL-12 and TNF-[alpha] production via adenosine A2a receptor-dependent and independent mechanisms. FASEB J. 14 (2000) 2065-2074
12. Hasko G., Pacher P., Vizi E.S., and Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol. Sci. 26 (2005) 511-516
13. Hasko G., Szabo C., Nemeth Z.H., Kvetan V., Pastores S.M., and Vizi E.S. Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J. Immunol. 157 (1996) 4634-4640
14. Huang S., Apasov S., Koshiba M., and Sitkovsky M. Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90 (1997) 1600-1610
15. Jacobson K.A., and Gao Z.G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5 (2006) 247-264
16. Kreckler L.M., Wan T.C., Ge Z.D., and Auchampach J.A. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J. Pharmacol. Exp. Ther. 317 (2006) 172-180
17. Lappas C.M., Sullivan G.W., and Linden J. Adenosine A2A agonists in development for the treatment of inflammation. Expert Opin. Investig. Drugs 14 (2005) 797-806
18. Levy O., Coughlin M., Cronstein B.N., Roy R.M., Desai A., and Wessels M.R. The adenosine system selectively inhibits TLR-mediated TNF-alpha production in the human newborn. J. Immunol. 177 (2006) 1956-1966
19. Lin P., Welch E.J., Gao X.P., Malik A.B., and Ye R.D. Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP. J. Immunol. 174 (2005) 2981-2989
20. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41 (2001) 775-787
21. MacKay R.J. Association between serum cytotoxicity and selected clinical variables in 240 horses admitted to a veterinary hospital. Am. J. Vet. Res. 53 (1992) 748-752
22. Martin L., Pingle S.C., Hallam D.M., Rybak L.P., and Ramkumar V. Activation of the adenosine A3 receptor in RAW 264.7 cells inhibits lipopolysaccharide-stimulated tumor necrosis factor-alpha release by reducing calcium-dependent activation of nuclear factor-kappaB and extracellular signal-regulated kinase 1/2. J. Pharmacol. Exp. Ther. 316 (2006) 71-78
23. Morris D.D. Endotoxemia in horses. A review of cellular and humoral mediators involved in its pathogenesis. J. Vet. Intern. Med. 5 (1991) 167-181
24. Shames B.D., McIntyre Jr. R.C., Bensard D.D., Pulido E.J., Selzman C.H., Reznikov L.L., Harken A.H., and Meng X. Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10. J. Surg. Res. 99 (2001) 187-193
25. Steverink P.J., Salden H.J., Sturk A., Klein W.R., van der Velden M.A., and Nemeth F. Laboratory and clinical evaluation of a chromogenic endotoxin assay for horses with acute intestinal disorders. Vet. Q. 16 (1994) S117-S121
26. Sun W.C., Cao Y., Jin L., Wang L.Z., Meng F., and Zhu X.Z. Modulating effect of adenosine deaminase on function of adenosine A1 receptors. Acta Pharmacol. Sin. 26 (2005) 160-165
27. Sun W.C., Moore J.N., Hurley D.J., Vandenplas M.L., and Murray T.F. Effects of stimulation of adenosine A(2A) receptors on lipopolysaccharide-induced production of reactive oxygen species by equine neutrophils. Am. J. Vet. Res. 68 (2007) 649-656
28. Sun W.C., Moore J.N., Hurley D.J., Vandenplas M.L., and Murray T.F. Pharmacologic characterization of novel adenosine A2A receptor agonists in equine neutrophils. Am. J. Vet. Res. 68 (2007) 981-987
29. Takahashi H.K., Iwagaki H., Hamano R., Wake H., Kanke T., Liu K., Yoshino T., Tanaka N., and Nishibori M. Effects of adenosine on adhesion molecule expression and cytokine production in human PBMC depend on the receptor subtype activated. Br. J. Pharmacol. 150 (2007) 816-822
30. Zhang J.G., Hepburn L., Cruz G., Borman R.A., and Clark K.L. The role of adenosine A2A and A2B receptors in the regulation of TNF-alpha production by human monocytes. Biochem. Pharmacol. 69 (2005) 883-889
31. Zhong H., Wu Y., Belardinelli L., and Zeng D. A2B adenosine receptors induce IL-19 from bronchial epithelial cells, resulting in TNF-alpha increase. Am. J. Respir. Cell Mol. Biol. 35 (2006) 587-592